A randomized controlled trial of buprenorphine taper duration among opioid-dependent adolescents and young adults

Addiction (Abingdon, England)

Volumn 111, Issue 8, 2016, Pages 1406-1415

  Marsch, Lisa A ^a   Moore, Sarah K ^b   Borodovsky, Jacob T ^a   Solhkhah, Ramon ^c   Badger, Gary J ^d   Semino, Shelby ^e   Jarrett, Kate ^f   Condon, Kathleen DiGangi ^g   Rossettie, Kate ^h   Vincent, Phillip ^c   Hajizadeh, Neda ^f   Ducat, Elizabeth ⁱ  

^a DARTMOUTH COLLEGE   (United States)

^b Capital Health Medical Center   (United States)

^c JERSEY SHORE UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^e The New York Public Library   (United States)

^f ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^g WINTHROP UNIVERSITY HOSPITAL   (United States)

^h Hudson Psychiatric Associates   (United States)

ⁱ ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Adolescent; buprenorphine; detoxification; opioid use disorder; treatment; Young adult

Indexed keywords

BUPRENORPHINE; NARCOTIC ANALGESIC AGENT;

ADOLESCENT; CLINICAL TRIAL; CONTROLLED STUDY; COUNSELING; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MOTIVATION; MULTICENTER STUDY; NEW YORK; OPIATE ADDICTION; RANDOMIZED CONTROLLED TRIAL; TIME FACTOR; YOUNG ADULT;

ADOLESCENT; ANALGESICS, OPIOID; BUPRENORPHINE; COUNSELING; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MOTIVATION; NEW YORK CITY; OPIOID-RELATED DISORDERS; TIME FACTORS; YOUNG ADULT;

EID: 84978086900     PISSN: None     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.13363     Document Type: Article

References (48)